Get the Stockscreener App
9.80
0.72%
0.07
After Hours:
9.80
Amicus Therapeutics Inc Stock (FOLD) Forecast
The Amicus Therapeutics Inc (FOLD) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $7.5317, representing a -23.15% decrease from the current price of $9.80. The highest analyst price target is $8.1153, and the lowest is $6.9481.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month FOLD Price Target
Average 10.67
(+8.84% Upside)
Is Amicus Therapeutics Inc (FOLD) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 45.87 | Neutral |
| STOCH(9,6) | 39.83 | Neutral |
| STOCHRSI(14) | 74.33 | Neutral |
| MACD(12,26) | -0.1662 | Buy |
| ADX(14) | 16.83 | Neutral |
| William %R | -51.39 | Neutral |
| CCI(14) | -33.13 | Neutral |
Buy: 1
Sell: 0
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
9.852
Sell
|
9.8037
Sell
|
| MA20 |
9.8405
Sell
|
9.9054
Sell
|
| MA50 |
10.49
Sell
|
10.25
Sell
|
| MA100 |
10.78
Sell
|
10.52
Sell
|
| MA200 |
10.64
Sell
|
10.86
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, FOLD could be considered a Strong Sell, with 17 technical analysis indicators signaling 1 Buy signals, 10 signaling Sell signals and 6 Neutral signals. This might not be a good time to consider opening new positions on FOLD, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 45.87 indicates that FOLD is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 39.83 indicates that FOLD is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 74.33 indicates that FOLD is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 16.83 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -33.13 indicates that FOLD is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term FOLD price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Amicus Therapeutics Inc financial reports and earnings history, Amicus Therapeutics Inc (FOLD) stock could reach $8.3328 by 2030, $6.0479 by 2040 and $2.0467 by 2050. See the projected annual prices until 2050 of the Amicus Therapeutics Inc stock below:
- Amicus Therapeutics Inc (FOLD) is expected to reach an average price of $6.7631 in 2035, with a high prediction of $8.0175 and a low estimate of $5.8675. This indicates an $-30.99% rise from the last recorded price of $9.80.
- Amicus Therapeutics Inc (FOLD) stock is projected to chart a bullish course in 2040, with an average price target of $5.6571, representing an $-42.27% surge from its current level. The forecast ranges from a conservative $4.9695 to a sky-high $6.0479.
- Our analysts predict Amicus Therapeutics Inc (FOLD) to jump -75.80% by 2045, soaring from $1.8206 to an average price of $2.3718, potentially reaching $3.365. While $1.8206 is the low estimate, the potential upside is significant.
- Amicus Therapeutics Inc (FOLD) stock is expected to climb by 2050, reaching an average of $0.1957, a $-98.00% jump from its current level. However, a wide range of estimates exists, with high and low targets of $2.0467 and $1.7857, respectively, highlighting the market's uncertainty.
Amicus Therapeutics Inc Stock (FOLD) Year by Year Forecast
Amicus Therapeutics Inc Stock (FOLD) Price Forecast for 2025
Amicus Therapeutics Inc Stock (FOLD) is expected to reach an average price of $10.67 in 2025, with a high prediction of $17.30 and a low estimate of $4.0334. This indicates an +8.84% rise from the last recorded price of $9.80.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $6.9481 | $6.9481 | $8.1153 | -29.10% |
| February, 2025 | $6.6287 | $6.4587 | $8.5923 | -32.36% |
| March, 2025 | $7.0442 | $6.5951 | $9.0665 | -28.12% |
| April, 2025 | $6.8612 | $4.0334 | $8.6248 | -29.99% |
| May, 2025 | $9.6018 | $6.4176 | $10.07 | -2.02% |
| June, 2025 | $9.3974 | $8.8074 | $10.77 | -4.11% |
| July, 2025 | $12.91 | $8.293 | $12.91 | +31.78% |
| August, 2025 | $13.34 | $12.52 | $13.94 | +36.12% |
| September, 2025 | $13.23 | $11.91 | $13.94 | +34.95% |
| October, 2025 | $11.43 | $10.64 | $13.56 | +16.66% |
| November, 2025 | $11.95 | $10.60 | $12.47 | +21.92% |
| December, 2025 | $15.67 | $11.30 | $17.30 | +59.85% |
Amicus Therapeutics Inc Stock (FOLD) Price Forecast for 2026
The predicted value for Amicus Therapeutics Inc (FOLD) in 2026 is set at an average of $14.87. Estimates vary from a peak of $23.24 to a trough of $6.4924, indicating an +51.68% surge from the present price of $9.80.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $21.08 | $15.44 | $21.10 | +115.11% |
| February, 2026 | $21.82 | $19.00 | $22.47 | +122.62% |
| March, 2026 | $19.69 | $19.20 | $23.24 | +100.89% |
| April, 2026 | $10.08 | $9.4789 | $20.03 | +2.85% |
| May, 2026 | $8.1144 | $7.5617 | $10.35 | -17.20% |
| June, 2026 | $7.06 | $6.6972 | $8.4158 | -27.96% |
| July, 2026 | $7.367 | $6.8814 | $8.3856 | -24.83% |
| August, 2026 | $8.5026 | $6.5598 | $8.6576 | -13.24% |
| September, 2026 | $7.5096 | $6.8896 | $8.724 | -23.37% |
| October, 2026 | $8.4052 | $6.4924 | $8.4602 | -14.23% |
| November, 2026 | $9.2908 | $7.898 | $9.3608 | -5.20% |
| December, 2026 | $7.4677 | $7.4177 | $10.01 | -23.80% |
Amicus Therapeutics Inc Stock (FOLD) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Amicus Therapeutics Inc (FOLD) is $7.3049, with a high forecast of $10.74 and a low forecast of $3.8694. This indicates an -25.46% decrease from the last price of $9.80.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $8.4133 | $7.3191 | $9.8919 | -14.15% |
| February, 2027 | $9.2589 | $7.9947 | $10.45 | -5.52% |
| March, 2027 | $8.7659 | $7.7859 | $9.4145 | -10.55% |
| April, 2027 | $8.4615 | $6.3365 | $10.56 | -13.66% |
| May, 2027 | $6.9571 | $6.4543 | $8.2429 | -29.01% |
| June, 2027 | $5.8341 | $5.5413 | $7.5499 | -40.47% |
| July, 2027 | $7.4196 | $5.7155 | $8.2669 | -24.29% |
| August, 2027 | $5.7852 | $5.7102 | $7.7624 | -40.97% |
| September, 2027 | $5.9122 | $3.8694 | $5.9872 | -39.67% |
| October, 2027 | $7.3178 | $5.46 | $7.4278 | -25.33% |
| November, 2027 | $9.3434 | $7.4692 | $9.5234 | -4.66% |
| December, 2027 | $10.30 | $7.6276 | $10.74 | +5.11% |
Amicus Therapeutics Inc Stock (FOLD) Price Forecast for 2028
In 2028, Amicus Therapeutics Inc (FOLD) is projected to reach an average price of $9.4846, with a high projection of $11.87 and a low estimate of $7.1013. This indicates an -3.22% fall from the last price of $9.80.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $9.446 | $8.936 | $10.94 | -3.61% |
| February, 2028 | $8.4316 | $7.8502 | $9.7274 | -13.96% |
| March, 2028 | $7.9985 | $7.8243 | $9.3907 | -18.38% |
| April, 2028 | $9.4941 | $7.1013 | $9.8127 | -3.12% |
| May, 2028 | $9.6811 | $9.2905 | $10.73 | -1.21% |
| June, 2028 | $11.05 | $9.1553 | $11.63 | +12.72% |
| July, 2028 | $10.60 | $10.24 | $11.54 | +8.19% |
| August, 2028 | $9.4693 | $9.2393 | $11.87 | -3.37% |
| September, 2028 | $9.2548 | $8.8335 | $9.7507 | -5.56% |
| October, 2028 | $10.19 | $9.0212 | $10.23 | +3.98% |
| November, 2028 | $10.22 | $8.5932 | $10.54 | +4.26% |
| December, 2028 | $10.61 | $9.988 | $11.58 | +8.30% |
Amicus Therapeutics Inc Stock (FOLD) Price Forecast for 2029
The 2029 price forecast for Amicus Therapeutics Inc Stock (FOLD) is $10.22 on average, with a high prediction of $12.66 and a low estimate of $7.7837. This represents an +4.33% increase from the previous price of $9.80.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $11.68 | $9.7644 | $11.91 | +19.18% |
| February, 2029 | $10.93 | $10.28 | $12.16 | +11.49% |
| March, 2029 | $11.16 | $10.40 | $11.59 | +13.89% |
| April, 2029 | $8.5167 | $8.1125 | $11.18 | -13.09% |
| May, 2029 | $8.4937 | $7.7837 | $9.9337 | -13.33% |
| June, 2029 | $9.3093 | $8.0001 | $9.3193 | -5.01% |
| July, 2029 | $12.28 | $8.9107 | $12.66 | +25.36% |
| August, 2029 | $10.53 | $10.07 | $12.63 | +7.47% |
| September, 2029 | $11.64 | $10.09 | $12.14 | +18.75% |
| October, 2029 | $9.6445 | $9.4781 | $12.13 | -1.59% |
| November, 2029 | $8.73 | $8.36 | $10.05 | -10.92% |
| December, 2029 | $8.145 | $8.07 | $9.71 | -16.89% |
Amicus Therapeutics Inc Stock (FOLD) Price Forecast for 2030
Amicus Therapeutics Inc Stock (FOLD) is expected to reach an average price of $5.3324 in 2030, with a high forecast of $8.8479 and a low forecast of $1.8169. This signifies an -45.59% decrease from the last price of $9.80.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $6.884 | $5.7885 | $8.3328 | -29.76% |
| February, 2030 | $7.8651 | $6.7968 | $8.1968 | -19.74% |
| March, 2030 | $7.1363 | $7.0663 | $8.8479 | -27.18% |
| April, 2030 | $5.3125 | $5.1875 | $7.5722 | -45.79% |
| May, 2030 | $3.5065 | $3.3815 | $5.6431 | -64.22% |
| June, 2030 | $4.1526 | $2.6042 | $4.2942 | -57.63% |
| July, 2030 | $5.1516 | $3.6754 | $5.4741 | -47.43% |
| August, 2030 | $5.4328 | $4.82 | $6.3622 | -44.56% |
| September, 2030 | $5.0289 | $4.4139 | $5.8806 | -48.68% |
| October, 2030 | $6.5329 | $4.2323 | $6.8429 | -33.34% |
| November, 2030 | $3.0291 | $2.0591 | $6.4957 | -69.09% |
| December, 2030 | $4.8703 | $1.8169 | $6.4097 | -50.30% |
2.88%
2.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):